Sialodacryoadenitis (SDAV)

Sialodacryoadenitis, commonly abbreviated as SDAV or SDA, is a highly contagious viral disease caused by a coronavirus that primarily affects rats. This condition specifically targets the salivary glands, lacrimal glands (tear-producing glands), and Harderian glands located behind the eyes. The disease is named for its characteristic inflammation of these glandular structures, with "sialo" referring to saliva, "dacryo" referring to tears, and "adenitis" meaning gland inflammation.

SDAV is one of the most common viral infections seen in laboratory and pet rat populations worldwide. The virus spreads extremely rapidly through direct contact, aerosol transmission, and contaminated fomites such as bedding, food dishes, and cage materials. In colony settings, an outbreak can infect an entire population within days to weeks. While the virus primarily affects rats, it does not pose any known risk to humans or other household pets, making it species-specific in its transmission.

The impact of SDAV on affected rats can range from mild subclinical infection to severe, distressing symptoms that significantly affect quality of life during the acute phase. The most recognizable signs include dramatic swelling of the neck and face due to enlarged salivary glands, bulging eyes from inflammation of the Harderian and lacrimal glands, and the characteristic red porphyrin staining around the eyes and nose. While the acute phase can appear alarming to owners, the infection is typically self-limiting in otherwise healthy rats.

Despite its generally favorable prognosis in immunocompetent animals, SDAV requires proper veterinary assessment and supportive care to ensure affected rats remain comfortable and avoid secondary complications. An exotic veterinarian experienced with rats should evaluate any suspected cases, as the symptoms can mimic other serious conditions. Early intervention with supportive care can minimize complications such as eye damage, secondary bacterial infections, and respiratory distress. Owners should understand that while this virus cannot be treated with antiviral medications, proper nursing care significantly improves outcomes and comfort during recovery.

Sialodacryoadenitis is caused by a coronavirus belonging to the family Coronaviridae, specifically classified within the species Murine coronavirus. This virus is closely related to other rat coronaviruses including Parker's Rat Coronavirus (RCV) and rat respiratory virus. The SDAV strain has a particular affinity for glandular and respiratory epithelial tissues, which explains its characteristic pattern of affecting the salivary glands, lacrimal apparatus, and respiratory tract simultaneously.

Transmission of SDAV occurs through multiple routes, making it extraordinarily contagious in rat populations. Direct contact between infected and susceptible rats is the primary transmission method, with the virus shed in respiratory secretions, saliva, and tears. Aerosol transmission allows the virus to spread between cages and across rooms, particularly in enclosed spaces with poor ventilation. Fomite transmission through contaminated bedding, food, water bottles, cage accessories, and even on handlers' hands or clothing contributes to rapid spread within colonies or multi-rat households.

Environmental and husbandry factors significantly influence susceptibility and disease severity. Rats housed in overcrowded conditions, experiencing chronic stress, or maintained in suboptimal environmental conditions face higher infection rates and more severe disease manifestations. Poor ventilation concentrates viral particles in the air, while inadequate cage hygiene allows the virus to persist on surfaces. Temperature extremes and inappropriate humidity levels can compromise respiratory defenses, making rats more vulnerable to infection and complications.

Dietary factors play an indirect but important role in disease susceptibility and recovery. Rats receiving inadequate nutrition, particularly those deficient in vitamins A, C, and E or essential fatty acids, may have compromised immune function that allows more severe infection. Protein deficiency can impair antibody production and cellular immunity, prolonging the course of infection. Conversely, well-nourished rats with robust immune systems typically experience milder symptoms and faster recovery.

The pathophysiology of SDAV involves viral replication within the epithelial cells of target glands and respiratory tissues. Upon initial infection, the virus replicates in the nasal passages before spreading to the salivary glands, lacrimal glands, and Harderian glands. This replication causes acute inflammation and necrosis of glandular tissue, resulting in the dramatic swelling observed clinically. The Harderian gland inflammation causes increased intraorbital pressure, leading to the characteristic eye bulging. Simultaneously, lacrimal gland dysfunction results in decreased tear production and increased porphyrin secretion, creating the red staining around eyes and nose known as chromodacryorrhea. The immune response eventually clears the virus, typically within two to four weeks, with glandular tissue regenerating over subsequent weeks to months.

Early warning signs of SDAV infection may be subtle and easily overlooked by owners unfamiliar with the disease. Initial symptoms often include mild lethargy, slightly decreased appetite, and increased sneezing or nasal discharge. Affected rats may show increased grooming of the face and eyes, and observant owners might notice slight puffiness around the eyes or jaw before more dramatic swelling develops. Since rats are prey animals that instinctively hide illness, these early behavioral changes warrant close monitoring and prompt veterinary consultation.

The most recognizable symptom of SDAV is pronounced swelling of the neck and submandibular region due to inflammation of the salivary glands, particularly the submandibular and parotid glands. This swelling can become quite dramatic, giving affected rats a characteristic "mumps-like" appearance with a thick, swollen neck that may obscure the normal jaw contours. The swelling is typically bilateral but may be asymmetric in some cases. This inflammation usually develops within three to seven days of initial infection and can persist for one to two weeks before gradually resolving.

Ocular symptoms are often the most distressing aspect of SDAV for both rats and their owners. Inflammation of the Harderian gland, located behind the eye, causes increased intraorbital pressure that pushes the eyes forward, creating a bulging or proptotic appearance. In severe cases, the eyes may protrude significantly, and affected rats may have difficulty closing their eyelids completely. This incomplete lid closure puts the cornea at risk for desiccation and ulceration. Concurrently, lacrimal gland inflammation reduces normal tear production while increasing porphyrin secretion, resulting in the characteristic red-brown staining around the eyes known as chromodacryorrhea. This red discharge, sometimes mistaken for blood by alarmed owners, is actually porphyrin, a normal component of rat tears that becomes more visible when tear production is altered.

Respiratory symptoms frequently accompany the glandular manifestations of SDAV. Affected rats commonly exhibit sneezing, nasal discharge ranging from clear to mucopurulent, and audible respiratory sounds including clicking, wheezing, or rattling. These respiratory signs result from viral infection of the nasal passages and potential secondary bacterial involvement. Some rats develop more significant lower respiratory involvement with labored breathing, increased respiratory rate, and reduced activity tolerance.

Behavioral changes during active SDAV infection reflect the systemic nature of the illness. Affected rats typically show decreased appetite, reduced water intake, and significant lethargy. Social rats may become withdrawn and less interactive with cagemates or handlers. Nesting behavior often increases as sick rats seek warmth and security. Some rats develop photophobia and prefer darker areas of their enclosure due to ocular discomfort. Weight loss during the acute phase is common and should be monitored carefully.

Emergency symptoms requiring immediate veterinary intervention include severe eye protrusion with inability to close the eyelids, corneal ulceration visible as cloudiness or opacity on the eye surface, complete refusal to eat or drink for more than 24 hours, severe respiratory distress with open-mouth breathing or cyanosis (blue discoloration of extremities), and extreme lethargy or unresponsiveness. Additionally, any signs of secondary bacterial infection such as purulent discharge, fever, or rapidly worsening condition warrant urgent veterinary care. Rats with compromised immune systems, very young rats, or geriatric rats are at higher risk for severe complications and should receive veterinary attention at the first sign of symptoms.

Diagnosis of sialodacryoadenitis typically begins with a thorough physical examination by a veterinarian experienced in rat medicine. The clinical presentation of bilateral salivary gland swelling, ocular changes, and respiratory symptoms creates a highly suggestive pattern that experienced exotic veterinarians can often recognize on initial presentation. The veterinarian will carefully palpate the submandibular region to assess glandular enlargement, examine the eyes for proptosis and corneal integrity, and auscultate the respiratory tract for abnormal sounds indicating lower airway involvement.

While definitive laboratory diagnosis is possible, it is not always performed in pet rat practice due to cost considerations and the self-limiting nature of the disease in most cases. When laboratory confirmation is desired, several testing methods are available. Serological testing can detect antibodies against SDAV, though antibodies may not be present in the earliest stages of infection and persist long after recovery, complicating interpretation. Polymerase chain reaction (PCR) testing can detect viral genetic material in respiratory secretions, tears, or tissue samples during active infection, providing more definitive acute diagnosis. In research settings, virus isolation and immunohistochemistry may be performed, though these techniques are rarely necessary for clinical management of pet rats.

Species-specific diagnostic considerations for rats include recognition that SDAV has a characteristic clinical course and appearance that distinguishes it from other conditions. The combination of salivary gland swelling, ocular proptosis, chromodacryorrhea, and respiratory symptoms occurring simultaneously is highly suggestive of SDAV. The veterinarian may perform fluorescein staining of the cornea to check for ulceration, particularly in rats with significant eye proptosis. Blood work may be recommended to assess overall health status and rule out concurrent infections, though there are no specific blood changes diagnostic for SDAV. Radiographs or other imaging are typically unnecessary unless lower respiratory disease is suspected.

Differential diagnosis for SDAV includes other conditions that can cause facial swelling, ocular changes, or respiratory symptoms in rats. Dental disease and tooth root abscesses can cause facial swelling but typically present unilaterally and without the characteristic ocular involvement. Upper respiratory infections from Mycoplasma pulmonis or secondary bacterial pathogens may cause similar respiratory symptoms but lack the dramatic glandular swelling. Trauma to the face or eyes requires consideration, particularly in rats housed with aggressive cagemates. Neoplasia affecting salivary glands or orbital structures would typically present more gradually and unilaterally. Pituitary tumors, common in older rats, can cause eye changes but follow a different clinical pattern. The veterinarian will consider the patient's history, housing situation, and potential exposure to other rats when formulating the diagnostic plan.

There is no specific antiviral treatment for sialodacryoadenitis, as the disease is caused by a coronavirus for which no targeted therapy exists in veterinary medicine. Treatment focuses entirely on supportive care to maintain the rat's comfort and overall health while the immune system clears the infection naturally. Immediate treatment priorities include ensuring adequate hydration and nutrition, protecting the eyes from secondary damage, and addressing any respiratory complications. In most cases, immunocompetent rats recover fully within two to four weeks with appropriate supportive care.

Medical management may include anti-inflammatory medications to reduce swelling and discomfort, though these must be used cautiously in rats. Meloxicam is commonly prescribed for its anti-inflammatory and analgesic properties, with careful attention to species-appropriate dosing. Antibiotics are not effective against the viral infection itself but may be prescribed if secondary bacterial infection is suspected or confirmed, particularly in rats with purulent nasal discharge or worsening respiratory symptoms. Commonly used antibiotics in rats include enrofloxacin, doxycycline, or azithromycin, often in combination for respiratory infections. All medications must be dosed carefully for the individual rat's weight, as small mammals have narrow therapeutic margins.

Ocular supportive care is critical for preventing permanent eye damage in rats with significant proptosis. Artificial tears or lubricating ophthalmic ointments should be applied multiple times daily to prevent corneal desiccation, especially in rats that cannot fully close their eyelids. If corneal ulceration is present, antibiotic ophthalmic drops or ointment will be prescribed to prevent bacterial superinfection. In severe cases with extreme proptosis, temporary tarsorrhaphy (partial suturing of the eyelids) may be necessary to protect the cornea until inflammation subsides. Owners should monitor the eyes closely for signs of worsening such as increased cloudiness, discharge, or apparent pain.

Supportive care at home forms the cornerstone of SDAV treatment. Affected rats should be kept in a quiet, warm, stress-free environment with easy access to food and water. Environmental temperature should be maintained at the warmer end of the comfortable range, around 72-78°F (22-26°C), as sick rats have difficulty thermoregulating. Humidity should be maintained at 40-60% to support respiratory health. High-value, soft foods may encourage eating in rats with reduced appetite or difficulty chewing due to facial swelling. Suitable options include baby food, cooked oatmeal, mashed banana, or commercially available critical care formulas designed for small mammals.

Species-specific treatment considerations for rats include their social nature and stress responses. Separating sick rats from healthy cagemates may reduce transmission but must be balanced against the stress of social isolation, which can impair recovery. If the entire colony is already exposed, keeping bonded rats together may be preferable. Rats stressed by isolation may benefit from maintaining visual and olfactory contact with companions while in separate enclosures. Handling should be gentle and minimized to essential care activities during the acute phase.

Treatment challenges specific to SDAV include the balance between isolation and social needs, the difficulty of medicating small patients, and the dramatic appearance of symptoms that may cause owner distress. Oral medications can be mixed with palatable foods such as baby food, yogurt, or commercial treat pastes to improve compliance. Eye treatments require gentle restraint and patience, as facial swelling may make rats head-shy. Owners should be counseled that the dramatic appearance of swelling and eye changes typically resolves completely, though improvement may take several weeks. Regular rechecks with the veterinarian ensure appropriate progress and allow treatment adjustments as needed.

Recovery from sialodacryoadenitis follows a predictable timeline in most immunocompetent rats, though individual variation exists based on age, overall health, and disease severity. The acute phase of symptomatic illness typically lasts one to two weeks, during which salivary gland swelling, ocular changes, and respiratory symptoms are most pronounced. Most rats begin showing improvement by the end of the second week, with swelling gradually subsiding and appetite returning. Complete resolution of all symptoms usually occurs within three to four weeks, though some rats may take up to six weeks for full recovery.

Post-treatment care and monitoring should continue throughout the recovery period and for several weeks afterward. Owners should monitor food and water intake carefully, ensuring affected rats return to normal consumption patterns. Body weight should be tracked weekly to confirm recovery and catch any setbacks early. Eyes should be observed for complete resolution of proptosis and any signs of residual corneal damage. Respiratory sounds should gradually improve, with complete resolution of sneezing and abnormal breathing sounds expected by four to six weeks post-infection. Any recurrence or worsening of symptoms warrants veterinary reevaluation.

Prognosis for SDAV is generally excellent in otherwise healthy rats receiving appropriate supportive care. The vast majority of immunocompetent rats recover fully without permanent sequelae. However, several factors influence individual prognosis. Young rats and geriatric rats face higher risks of complications and may require more intensive supportive care. Rats with preexisting health conditions, particularly respiratory disease or immunocompromising conditions, may experience more severe or prolonged illness. Corneal damage occurring during the acute phase may result in permanent scarring or vision impairment if not adequately treated. Secondary bacterial infections can prolong recovery and occasionally prove more dangerous than the viral infection itself.

Long-term outlook following SDAV recovery is generally favorable, with most rats returning to normal health and quality of life. Recovered rats develop immunity to the specific strain that infected them, though the duration of immunity and cross-protection against other coronavirus strains is not fully characterized. Some rats may experience residual changes to salivary gland function, though this rarely causes clinical problems. Owners should be aware that chronic respiratory issues in rats are often multifactorial, and prior SDAV infection may be one contributing factor to long-term respiratory health. Regular veterinary check-ups and attention to respiratory health remain important throughout the rat's life. The emotional bond between owners and their rats typically strengthens through the shared experience of nursing a pet through SDAV recovery.

Preventing sialodacryoadenitis requires attention to biosecurity practices, particularly for owners with multiple rats or those who attend events where rats from different sources come into contact. Quarantine protocols are the cornerstone of SDAV prevention for rat owners acquiring new animals. All new rats should be quarantined in a completely separate airspace from existing rats for a minimum of three weeks, ideally four to six weeks. This means housing new arrivals in a different room with no shared ventilation, using separate equipment, and handling quarantined rats after existing rats with thorough hand washing and clothing changes between groups.

Dietary prevention focuses on supporting robust immune function through optimal nutrition. Rats should receive a high-quality commercial lab block or pellet as the dietary foundation, supplemented with fresh vegetables, occasional fruits, and appropriate protein sources. Foods rich in vitamins A, C, and E support immune function and respiratory epithelial health. Avoid nutritional deficiencies that could compromise immune response, and ensure fresh, clean water is always available. Probiotic supplementation may support overall immune health, though direct prevention of viral diseases has not been proven.

Stress reduction plays an important role in disease prevention and in minimizing severity if infection occurs. Rats should be housed in appropriately sized enclosures with enrichment opportunities, hiding places, and social companionship. Avoid overcrowding, which increases disease transmission and causes chronic stress. Maintain consistent routines and minimize unnecessary handling or environmental disruptions. Provide appropriate temperatures and humidity levels, as environmental stress compromises immune function. Address any sources of chronic stress such as incompatible cagemates, inappropriate substrate, or inadequate hiding opportunities.

Regular health monitoring enables early detection of SDAV and other conditions. Owners should observe their rats daily for signs of illness, including changes in appetite, activity level, respiratory sounds, and appearance of eyes and face. Weekly weighing helps detect early weight loss that might indicate developing illness. Establish baseline vital signs and behavioral patterns for each rat to recognize subtle changes that might indicate early infection. Early detection allows for prompt supportive care and potential isolation to reduce transmission.

Veterinary care with an exotic specialist experienced in rat medicine supports overall health and disease prevention. Establish a relationship with a qualified veterinarian before emergencies arise. Annual wellness examinations allow for early detection of health issues that might increase susceptibility to infectious diseases. Discuss biosecurity practices with your veterinarian, particularly if you attend rat shows, rescue rats, or otherwise encounter rats from outside your established colony. There is currently no vaccine available for SDAV in pet rats, making biosecurity and health optimization the primary prevention strategies.

Daily care requirements for rats recovering from SDAV or living in environments where the disease has occurred emphasize supportive husbandry and careful monitoring. During active illness, affected rats require multiple daily check-ins to assess hydration, food intake, and symptom progression. Fresh food and water should be provided daily, with attention to ensuring sick rats can easily access resources. Soft, nutritious foods may need supplementation if rats have difficulty eating due to facial swelling. Bedding should be kept clean and changed more frequently than usual to reduce irritants and maintain hygiene. Daily eye lubrication as prescribed by the veterinarian is essential for protecting corneal health.

Environmental management following an SDAV outbreak requires thorough cleaning and attention to ongoing biosecurity. Once all affected rats have recovered, perform a deep clean of all housing, accessories, and equipment. The SDAV virus is relatively fragile in the environment and can be inactivated by common disinfectants, heat, and drying. Clean and disinfect all cages, water bottles, food dishes, and accessories with appropriate disinfectants such as dilute bleach solution (1:32 dilution), allowed to air dry completely before reuse. Replace porous items that cannot be thoroughly disinfected, such as wooden accessories or fabric items. Maintain good ventilation in rat housing areas to reduce aerosol transmission risk.

Monitoring health indicators becomes especially important for rats that have experienced SDAV. Watch for signs of recurrent respiratory issues, which can develop if secondary bacterial infections were not completely resolved or if underlying Mycoplasma infection was exacerbated. Monitor eyes for any residual changes or signs of ongoing problems such as chronic discharge, cloudiness, or apparent vision deficits. Track body weight regularly to ensure full recovery and maintenance of healthy condition. Note any changes in eating or drinking habits, activity levels, or social interactions that might indicate persistent health issues.

Quality of life considerations for SDAV survivors focus on supporting complete recovery and long-term wellbeing. Most rats recover fully and return to normal quality of life, but owners should remain attentive to any lasting effects. Rats with residual eye damage may need ongoing monitoring and occasional lubrication. Those with chronic respiratory effects benefit from optimal environmental management including good ventilation, low-dust bedding, and avoidance of irritants. Maintain social housing for recovered rats, as the companionship of conspecifics supports psychological wellbeing and may enhance immune function.

Caregiver support and resources are important for owners managing SDAV in their rats. The dramatic appearance of symptoms can be distressing, and owners benefit from understanding the typically favorable prognosis and expected timeline of recovery. Online communities and rat-specific forums can provide support and shared experiences from owners who have managed SDAV successfully. Document the course of illness with photos and notes to share with your veterinarian and to reference for future comparison. The Rat Guide (ratguide.com) and similar evidence-based resources provide detailed information on SDAV and other rat health conditions. Remember that most rats recover fully with appropriate supportive care, and use this experience to strengthen biosecurity practices and deepen knowledge of rat health management.

Sialodacryoadenitis predominantly affects rats (Rattus norvegicus), with both domestic pet rats and laboratory rats being susceptible. The virus is highly species-specific and does not naturally infect mice, gerbils, hamsters, or other small rodent species. Within rat populations, certain groups face higher risk of severe disease. Young rats between weaning and approximately three months of age may experience more significant illness due to their developing immune systems. Geriatric rats, typically those over two years of age, also face increased risk due to age-related immune decline and frequent concurrent health conditions.

Age, sex, and genetic factors influence SDAV susceptibility and disease severity in various ways. There is no clear sex predisposition to SDAV infection, with males and females equally susceptible. However, pregnant or nursing females may experience more stress-related immunosuppression that could worsen disease course. Certain genetic lines may have varying susceptibility, though this is more documented in laboratory settings than in pet rat populations. Inbred strains may show different responses to infection compared to outbred pet rats. Immunocompromised rats from any cause, including those with underlying disease, malnutrition, or chronic stress, face higher risk of severe infection and complications.

Species-specific susceptibilities make rats particularly vulnerable to SDAV in certain circumstances. Rats housed in colonies or multi-rat households face the highest exposure risk due to the extremely contagious nature of the virus. Those in breeding colonies, rescue situations, or shelters encounter elevated risk due to exposure to rats from multiple sources. Rats attending shows or events where multiple breeders bring animals face transmission risk despite best biosecurity efforts. Laboratory rats historically faced high SDAV rates before improved biosecurity protocols were implemented. Pet rats in single-rat households with no outside exposure have the lowest risk but are not immune if the virus is introduced through contaminated materials, visiting rats, or human fomite transmission. Owners who work with rats in other settings or who volunteer at rescues should practice careful biosecurity to protect their home colonies.

Sialodacryoadenitis frequently co-occurs with or leads to secondary conditions that complicate the clinical picture. Mycoplasmosis, the chronic respiratory disease caused by Mycoplasma pulmonis, is present in the majority of pet rats and can be activated or worsened by SDAV infection. The respiratory component of SDAV may trigger mycoplasma flare-ups that persist after the viral infection clears, leading to chronic respiratory issues requiring ongoing management. Secondary bacterial pneumonia can develop when respiratory defenses are compromised by viral infection, requiring antibiotic therapy in addition to supportive care.

Conditions with similar symptoms to SDAV require differentiation during diagnosis. Upper respiratory infections from various bacterial pathogens can cause similar sneezing and nasal discharge but typically lack the dramatic salivary gland swelling. Dental disease, including tooth root abscesses and malocclusion, can cause facial swelling but usually presents unilaterally and without ocular involvement. Chromodacryorrhea (red tears) occurs in many stress or illness conditions and is not specific to SDAV. Other coronavirus infections in rats may cause similar or overlapping syndromes. Neoplasia of the salivary glands or orbital region would typically present more gradually and unilaterally rather than with acute bilateral swelling.

Secondary complications from SDAV require monitoring during and after infection. Corneal ulceration is a significant potential complication in rats with severe eye proptosis, resulting from exposure and desiccation when eyelids cannot close completely. Untreated corneal damage can lead to permanent scarring, vision impairment, or in severe cases, loss of the eye. Dehydration and malnutrition develop if rats cannot eat or drink adequately during acute illness, potentially prolonging recovery. Inner ear involvement can occasionally occur, leading to vestibular signs such as head tilt or circling, though this is less common. Chronic respiratory disease may persist or develop following SDAV, particularly in rats with preexisting Mycoplasma infection or those who experienced secondary bacterial infection during the acute phase.